Rubric : Topical
Chemotherapy-induced thrombocytopenia: current management strategies and prospects for the use of eltrombopag in UkraineAuthor:Syvak L.A. Т. 16, №2 (62)
Systemic treatment of locally advanced and metastatic EGFR-mutated NSCLC. What’s new?Т. 16, №2 (62)
Clinical efficacy of dual HER2 blockade in HER2-positive breast cancerAuthors: Martyniuk O.M. Smolanka I.I. Chapyk I.I. Т. 16, №2 (62)
Lonsurf® as a cardio-gentle alternative to classical fluoropyrimidinesAuthor:Lyalkin S.A. Т. 16, №1 (61)
Topic immunotherapy with 5% imiquimod in complex clinical scenarios of basal cell skin cancerAuthors: Lytvynenko B.V. Litus M.O. Т. 16, №1 (61)
A Multidisciplinary Approach to Breast Cancer Treatment in Historical Perspective
From theory to practice. The art of lung cancer treatment
The era of «targets» in the treatment strategy of resectable NSCLC: from ADAURA to NeoADAURA…Т. 14, №2 (54)
New opportunities in first-line therapy of unresectable EGFRm NSCLC. Overview of clinical trials FLAURA, FLAURA2, LAURAТ. 14, №2 (54)
Modern aspects of diagnosis and treatment of kidney cancer
New therapeutic options in the treatment of patients with relapsed/refractory B-cell acute lymphoblastic leukemiaТ. 14, №1 (53)
Disease-free survival as a predictor of overall survival in localized renal cell carcinoma following initial nephrectomy: а retrospective analysis of Surveillance, Epidemiology and End Results-Medicare data
Vaccination as a primary prophylaxis against tumors caused by HPVAuthors: Patsko V.V. Efimenko O.V. Lukashenko A.V. Т. 14, №1 (53)
Expanding the role of immuno-oncology treatment in the management of patients with melanoma or triple-negative breast cancerТ. 13, №4 (52)
New stage in personalized breast cancer therapy: a chance for recovery
